Sara Neyt
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
In vivo PET imaging of zebrafish and its application for detecting metabolic changes in response to lipopolysaccharide.
Journal: Comparative biochemistry and physiology. Part A, Molecular & integrative physiology
Published: December 22, 2025
Cross-Modality Deep Learning Denoising for Low-Dose μSPECT: Transfer of PET-Trained U‑Net and Diffusion Models.
Journal: Chemical & biomedical imaging
Published: December 22, 2025
Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level.
Journal: Journal of visualized experiments : JoVE
Published: February 10, 2025
The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 13, 2024
The development of 177Lu-DOTA-CC-PSMA following a unified "Click Chemistry" protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals.
Journal: EJNMMI radiopharmacy and chemistry
Published: May 21, 2024
Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging.
Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2020
In Vivo Measurement of Hepatic Drug Transporter Inhibition with Radiolabeled Bile Acids.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 25, 2019
Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease.
Journal: Nuclear medicine and biology
Published: September 07, 2018
Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
Journal: PloS one
Published: July 20, 2018
Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease.
Journal: Hepatology (Baltimore, Md.)
Published: June 12, 2018
Last Updated: 09/26/2026